Table 2.
Important findings for extracellular vesicles in the context of NAFLD.
Key Study Findings | Disease Model | Vesicle Source | Methods | Citation | |
---|---|---|---|---|---|
Rodent | NAFLD-inducing diet increases circulating EV abundance | HFD CDD |
plasma | FC | [74,75,76] |
Circulating EV abundance correlates with NAFLD progression | CDD | plasma | FC | [75,76] | |
NAFLD-inducing diet increases circulating liver-derived EVs | HFD CDD |
plasma serum |
RT-qPCR | [75,76,77] | |
NAFLD-inducing diet changes circulating EV contents | CDD | plasma | LCMS WB |
[75,76] | |
NAFLD-inducing diet changes circulating EV interactions with cells | HFD | plasma | FC | [79] | |
Human | Circulating EV abundance correlates with NAFLD progression | NASH | plasma | FC | [72] |
Circulating EV contents can distinguish NAFLD from other liver diseases | NASH | plasma serum |
FC microarray |
[72,82] |
Abbreviations: CDD = choline deficient diet, EV = extracellular vesicle, FC = flow cytometry, HFD = high-fat diet, LCMS = liquid chromatography with mass spectrometry, NAFLD = non-alcoholic fatty liver disease, NASH = non-alcoholic steatohepatitis, RT-qPCR = real-time quantitative polymerase chain reaction, WB = western blot.